MoneyWorks4Me

Lasa Supergenerics - Quaterly Results

08 Aug 2022 Evaluate
The sales for the June 2022 quarter moved down to Rs. 288.79 millions as compared to Rs. 360.66 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -120.84 millions as compared to Net Profit of Rs. 8.06 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -81.19% as compared to 46.42% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 288.79 360.66 -19.93 288.79 360.66 -19.93 1371.27 2023.80 -32.24
Other Income 0.09 0.15 -40.00 0.09 0.15 -40.00 0.57 0.58 -1.72
PBIDT -81.19 46.42 -274.90 -81.19 46.42 -274.90 156.89 472.79 -66.82
Interest 0.09 0.28 -67.86 0.09 0.28 -67.86 0.40 19.63 -97.96
PBDT -81.28 46.14 -276.16 -81.28 46.14 -276.16 77.89 453.16 -82.81
Depreciation 30.66 34.71 -11.67 30.66 34.71 -11.67 139.99 158.24 -11.53
PBT -111.94 11.43 -1079.35 -111.94 11.43 -1079.35 -62.10 294.92 -121.06
TAX 8.90 3.37 164.09 8.90 3.37 164.09 -8.42 67.14 -112.54
Deferred Tax 8.90 -0.84 -1159.52 8.90 -0.84 -1159.52 -14.62 56.47 -125.89
PAT -120.84 8.06 -1599.26 -120.84 8.06 -1599.26 -53.68 227.78 -123.57
Equity 406.73 406.73 0.00 406.73 406.73 0.00 406.73 406.73 0.00
PBIDTM(%) -28.11 12.87 -318.43 -28.11 12.87 -318.43 11.44 23.36 -51.03
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..